Immatics N.V.
IMTX
Jodie situation report
Immatics N.V.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 21 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 3 directly disclosed connections are confirming.
- IMTX's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if IMTX's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind IMTX
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depended on by
EDITEditas Medicine, Inc.partnerMar 9, 2026 ▾
“We are also party to a non-exclusive collaboration and licensing agreement with Immatics to combine gamma-delta T cell adoptive cell therapies and gene editing for the treatment of cancer.”
Filing peers
No filing peers are available for this name yet.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 2 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
IMTX is currently a Follower in the organic co-movement group Oil & Gas and Biotech. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for IMTX; it is not active in the latest market snapshot.